Bgi Genomics Co.,Ltd.’s Net Profit Dropped 44.7% in First Half of 2022

Bgi Genomics Co.,Ltd. (深圳华大基因股份有限公司) (300676.SZ) reported a net profit of 605.5 million yuan in the first half of 2022, down 44.7% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, down 13.3% year-on-year.

At the end of the reporting period, it had 13.5 billion yuan in total assets and 3.6 billion yuan in total liabilities, with a liability-to-asset ratio of 26.6%.